Saturday, April 4, 2020

Fw: (LML) View COVID-19 research, resources, and information

Visit our COVID-19 collection and sign up for updates
View this email in your browser
PLOS
A Message to Our Community Regarding COVID-19

PLOS is committed to accelerating publication and disseminating research as quickly and openly as possible to support researchers, public health officials, and citizens around the world in their work to slow the spread of COVID-19.

We’re working on a number of initiatives to help our community find the COVID-19 research they need, in the way they want to receive it. Here’s how you can stay informed:
 

View Resources: COVID-19 Collection

Our Open Access collection highlights a range of work across all PLOS journals, including:

• Research articles

• Blog posts

• PLOS channels

Get Updates: COVID-19 Research Alerts

To help you keep up to date with the new research being published, we’ve created a dedicated COVID-19 Research Alert. Sign up to receive regular updates by email with links to newly published COVID-19 research articles.

For further COVID-19 research links and resources visit the Copyright Clearance Center.

We’re here to help our community in these uncertain times. If you need more information or further resources at any time, visit and bookmark our COVID-19 page for updates. Please do not hesitate to get in touch with us directly via email, or through social media.

Twitter Facebook Email
To discontinue email communications from PLOS, you can unsubscribe.
Update Profile   Terms of Use   Privacy Policy
PLOS
Public Library of Science
1160 Battery St. Suite 225, San Francisco, CA 94111, US
 

Leprosy Mailing List – April 4,  2020


Ref.:   (LML) View COVID-19 research, resources, and information


From:  PLOS journals and Academia, San Francisco, USA



Dear colleagues,

 

We received from PLOS Journals and ACADEMIA the following information regarding updates on the COVID-19 pandemic.

 

Best wishes in these difficult times,

 

Pieter AM Schreuder

Editor LML

 

PLOS Journals

 

 

PLOS is committed to accelerating publication and disseminating research as quickly and openly as possible to support researchers, public health officials, and citizens around the world in their work to slow the spread of COVID-19.

We're working on a number of initiatives to help our community find the COVID-19 research they need, in the way they want to receive it. Here's how you can stay informed:


View Resources: COVID-19 Collection

Our Open Access collection highlights a range of work across all PLOS journals, including:

 Research articles

 Blog posts

 PLOS channels


Get Updates: COVID-19 Research Alerts

To help you keep up to date with the new research being published, we've created a dedicated COVID-19 Research Alert. Sign up to receive regular updates by email with links to newly published COVID-19 research articles.



For further COVID-19 research links and resources visit the Copyright Clearance Center.

We're here to help our community in these uncertain times. If you need more information or further resources at any time, visit and bookmark our COVID-19 page for updates. Please do not hesitate to get in touch with us directly via email, or through social media.

 

Public Library of Science

San Francisco, USA

 

 



 



 

Dear Academia Community,

Academia has members and visitors from all around the world. Wherever you are right now, we are wishing you well. We hope this letter finds you in a place of safety and health. Our thoughts are with those of you who may be unwell, anxious, or grieving during this time.

We wanted to share an update about what is going on with Academia and Coronavirus. First of all, mercifully, the team is all healthy here. There's a shelter-in-place order for San Francisco and the Bay Area, so we are all working from home. That's going well so far - we are able to keep everything running, and the team is working at full strength.

Academia's mission is to Accelerate the World's Research. We feel that mission is particularly pertinent at this time. Our platform is able to provide access and distribution at a very large scale, so that's what we will do with Coronavirus and COVID-19 research.

We have put together a page highlighting some key research papers on the novel coronavirus and the COVID-19 disease. You can find it here. In addition to curated content, it also lists the related reading that our algorithms have found for those papers.

As always, we appreciate your help in creating and sharing this work. If you know of a paper that should be featured, please email us at coronavirus@academia.edu.

If you have written a related paper that you want to get out to the community, please upload it to your profile at academia.edu/Papers/Upload, and then let us know about it via the email address above.

Finally, we've made our Premium features free for Coronavirus- and COVID-19-related content. Advanced Search, Bulk Download, 5-minute Overviews, and Lists are available without a Premium account for all relevant searches and papers.

We are grateful for the important work that scientists, doctors, nurses, teachers, parents, and all others are doing at this time. Thank you from all of us here - we are proud you are our community. We'll continue to work on our mission and wish you well over the next weeks and months. Please let us know if you have any thoughts about what else we can do to help.

 

Our best wishes to you all, and take care,

 

Richard, Ben, Mitch, and the whole Academia team

San Francisco, USA


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 










 

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/fc6ad1a2-c2ab-4c13-9f49-9212b7914c87%40googlegroups.com.

No comments: